Key points are not available for this paper at this time.
Central retinal vein occlusion (CRVO) is one of a common cause of visual impairment. It commonly affects men and women equally and occurs predominantly in persons over the age of 65 years. In this population, there may be associated systemic vascular disease, including hypertension and diabetes. Younger individuals who present with clinical picture of CRVO may have underlying hypercoagulable or inammatory etiology. Sodium valproic acid is an antiepileptic drug extensively used for treating partial and generalised seizures, acute mania, and prophylaxis for bipolar disorder. VPA causes hepatotoxicity which in turn causes hypercoagulability. Drug induced liver injury(DILI) persists as signicant issue related to fatal outcomes by VPA. Here is a 35 yr old young patient with h/o intake of sodium valproate for 10 yrs, presented to our opd with B/L CRVO with hyperhomocysteine levels.
Anulekha et al. (Mon,) studied this question.